Van ECK Associates Corp lowered its holdings in shares of Mylan N.V. (NASDAQ:MYL) by 9.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 319,135 shares of the company’s stock after selling 32,524 shares during the period. Van ECK Associates Corp owned approximately 0.06% of Mylan N.V. worth $12,389,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the stock. UBS Asset Management Americas Inc. boosted its stake in Mylan N.V. by 6.2% during the second quarter. UBS Asset Management Americas Inc. now owns 1,252,705 shares of the company’s stock worth $48,630,000 after acquiring an additional 73,488 shares in the last quarter. Rafferty Asset Management LLC boosted its stake in Mylan N.V. by 34.8% during the second quarter. Rafferty Asset Management LLC now owns 51,420 shares of the company’s stock worth $1,996,000 after acquiring an additional 13,287 shares in the last quarter. Accident Compensation Corp boosted its stake in Mylan N.V. by 0.3% during the second quarter. Accident Compensation Corp now owns 71,035 shares of the company’s stock worth $2,758,000 after acquiring an additional 200 shares in the last quarter. Thrivent Financial For Lutherans boosted its stake in Mylan N.V. by 5.9% during the second quarter. Thrivent Financial For Lutherans now owns 289,840 shares of the company’s stock worth $11,252,000 after acquiring an additional 16,120 shares in the last quarter. Finally, ProShare Advisors LLC boosted its stake in Mylan N.V. by 4.0% during the second quarter. ProShare Advisors LLC now owns 473,235 shares of the company’s stock worth $18,371,000 after acquiring an additional 18,002 shares in the last quarter. 71.97% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “Van ECK Associates Corp Reduces Position in Mylan N.V. (MYL)” was originally posted by Daily Political and is the property of of Daily Political. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://www.dailypolitical.com/2017/09/23/van-eck-associates-corp-reduces-position-in-mylan-n-v-myl.html.

Shares of Mylan N.V. (NASDAQ:MYL) opened at 31.30 on Friday. Mylan N.V. has a 12 month low of $29.39 and a 12 month high of $45.87. The company has a market capitalization of $16.79 billion, a price-to-earnings ratio of 25.30 and a beta of 1.31. The company’s 50-day moving average is $31.89 and its 200 day moving average is $37.29.

Mylan N.V. (NASDAQ:MYL) last posted its earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.18 by ($0.08). The firm had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $3 billion. Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. Mylan N.V.’s revenue for the quarter was up 15.7% compared to the same quarter last year. During the same period last year, the firm earned $1.16 earnings per share. On average, equities research analysts anticipate that Mylan N.V. will post $4.52 earnings per share for the current year.

MYL has been the subject of several recent analyst reports. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $34.00 target price on shares of Mylan N.V. in a report on Friday, September 8th. BidaskClub raised shares of Mylan N.V. from a “strong sell” rating to a “sell” rating in a report on Thursday, September 7th. ValuEngine cut shares of Mylan N.V. from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Argus cut shares of Mylan N.V. from a “buy” rating to a “hold” rating and decreased their target price for the stock from $47.59 to $29.39 in a report on Tuesday, August 22nd. Finally, Mizuho reaffirmed a “buy” rating and issued a $37.00 target price (down from $53.00) on shares of Mylan N.V. in a report on Sunday, August 20th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $43.43.

Mylan N.V. Profile

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan N.V. (NASDAQ:MYL).

Institutional Ownership by Quarter for Mylan N.V. (NASDAQ:MYL)

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.